Idexx Laboratories, Inc. Earnings

Idexx Laboratories, Inc.’s revenue jumped 14.28% since last year same period to $1090.58Mn in the Q4 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -1.33% fall in its revenue since last 3-months.

Idexx Laboratories, Inc.’s net profit jumped 14.82% since last year same period to $248.19Mn in the Q4 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -9.62% fall in its net profits since last 3-months.

Idexx Laboratories, Inc.’s net profit margin jumped 0.47% since last year same period to 22.76% in the Q4 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated -8.41% fall in its net profit margins since last 3-months.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.34 - a 13.61% jump from last quarter’s estimates.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 3.34.

Idexx Laboratories, Inc.’s earning per share (EPS) jumped 21.43% since last year same period to 3.4 in the Q3 2025. This indicates that the Idexx Laboratories, Inc. has generated 21.43% annual rate of jump in its earning per share (EPS) in the last 4 quarters.